Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C16H15N3O5 |
| Molecular Weight | 329.3074 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(\C=N\NC(=O)C2=CC=NC=C2)C(C(O)=O)=C1OC
InChI
InChIKey=HSYFNANHKYNZNI-GIJQJNRQSA-N
InChI=1S/C16H15N3O5/c1-23-12-4-3-11(13(16(21)22)14(12)24-2)9-18-19-15(20)10-5-7-17-8-6-10/h3-9H,1-2H3,(H,19,20)(H,21,22)/b18-9+
| Molecular Formula | C16H15N3O5 |
| Molecular Weight | 329.3074 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [A study of the effect of saluzid on the metabolism of phosphorus compounds in the liver during experimental tuberculosis with the aid of radioactive phosphorus]. | 1962 |
|
| [Saluzid in the treatment of meningeal tuberculosis in children]. | 1958 |
|
| [Saluzid content of biological fluids in meningeal tuberculosis patients; dosage of preparation; clinical and experimental research]. | 1957 |
|
| [Saluzide in the treatment of tuberculous meningitis in adults]. | 1955-11-01 |
|
| [Effects of saluzide treatment on experimental tuberculous meningitis]. | 1955-11-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:06:26 GMT 2025
by
admin
on
Mon Mar 31 18:06:26 GMT 2025
|
| Record UNII |
KD4681N5W4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C280
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000083322
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
C90770
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
1095
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
CHEMBL1403144
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
m8217
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB09449MIG
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
C009200
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
KD4681N5W4
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
DTXSID6046185
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
2779-55-7
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY | |||
|
6871212
Created by
admin on Mon Mar 31 18:06:26 GMT 2025 , Edited by admin on Mon Mar 31 18:06:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |